Considerations for patient follow-up after onabotA administration

Follow-up after onabolulinumtoxinA (Botox) injection for overactive bladder (OAB) should be tailored to the patient’s needs, according to Benjamin M. Brucker, MD.

In an interview with Urology Times®, Bruker details key post-procedural recommendations laid out in the publication, “Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA.”¹

“If it's a first-time injection, in my personal practice and I think many out there, we might have someone come back to see how they're doing, to check a post-void residual, usually at about 2 weeks––maybe they see a nurse or a nurse practitioner, a care navigator. Not a bad idea to have that touch point. But for my patients that have demonstrated, for example, no issues with incomplete bladder emptying, I don't necessarily tell them they have to come back for a post-void residual because they've already proven that they're not having an issue,” Brucker explained.

Brucker is a urologist and urogynecologist at NYU Langone Health in New York, New York.

EP: 1.Optimizing onabotA for OAB: What are some common misconceptions?

EP: 2.Karyn S. Eilber, MD, on patient counseling for onabotA treatment for OAB

EP: 3.Administering onabotA: Improving patient comfort and easing anxiety

Now Viewing

EP: 4.Considerations for patient follow-up after onabotA administration

EP: 5.OnabotA for OAB: Enhancing comfort and ensuring adherence

EP: 6.From prep to follow-up: Key considerations for administering onabotulinumtoxinA